This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
“compound 12” is a selective inhibitor of integrin αvβ5, a potential target for sepsis due to its potential role in regulating…
molecule
2 years ago ●
1 min read
“compound 12j” is a potent agonist of the ghrelin hormone receptor, activation of which stimulates growth hormone secretion and appetite among…
molecule
2 years ago ●
1 min read
“compound 7f” is an antagonist of the endosomal TLRs 7/8/9, which induce inflammation in response to internalized single-stranded RNA or hypomethylated…
molecule
2 years ago ●
1 min read
DS34942424 is a potent oral analgesic discovered using the natural product conolidine as a starting point. While the authors were able…
molecule
2 years ago ●
1 min read
“compound 12” is a selective negative allosteric modulator of the GluN2B subunit of NDMA receptors intended for treatment of mood disorders.…
molecule
2 years ago ●
1 min read
“compound 37” is an inhibitor of the ATG7 E1 ligase through an interesting substrate-assisted covalent mechanism. Rather than covalently modify ATG7…
molecule
2 years ago ●
1 min read
Load More
